Abstract
BackgroundWhile biologics are a significant therapeutic advance for many conditions, there is a paucity of studies that directly assess their comparative safety making choosing between them a difficult clinical decision.ObjectivesTo...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
